CollPlant Biotechnologies Ltd. announced that its ordinary shares will begin trading on Nasdaq under the new ticker symbol "OPHI," effective November 13, 2026. This change is part of the company's strategy to expand its focus on photonic computing, specifically leveraging LightSolver's all-optical Laser Processing Unit (LPU).
The current ticker symbol "CLGN" will remain in use until the close of trading on November 12, 2026. The company indicated that no action is required from shareholders regarding this ticker symbol change, and the shares will continue to be listed on Nasdaq without any alteration to the CUSIP number.
CEO Eran Rotem stated, "Changing our ticker symbol to OPHI reflects our strategic expansion into photonic computing. By building our future around LightSolver's LPU technology, we believe we are positioned to address next-generation computing demands and deliver long-term value to our shareholders." This sentiment is echoed by Dr. Ruti Ben Shlomi, Co-Founder and CEO of LightSolver, who highlighted the LPU's potential to solve demanding workloads more efficiently.
In addition to the ticker change, CollPlant plans to change its name to OptiPhi Computing Ltd., pending shareholder approval at an extraordinary general meeting scheduled for November 24, 2026, and consent from the Israeli Registrar of Companies. This name change is intended to better align with the company's new strategic direction.
Background
CollPlant Biotechnologies Ltd. is a technology company specializing in advanced biotechnology and photonic computing. It operates under the Standard Industrial Classification (SIC) code 3842, which pertains to orthopedic, prosthetic, and surgical appliances and supplies. The company is listed on the Nasdaq under the ticker symbol CLGN.
What the Filing Says
According to the filing dated November 12, 2026, "CollPlant to Begin Trading on Nasdaq Under New Ticker Symbol 'OPHI'" is the title of the press release attached as Exhibit 99.1. The filing confirms the transition of the ticker symbol and outlines the strategic focus on photonic computing.
Impact
This change may affect shareholders and investors who are interested in the company's future direction and performance in the photonic computing sector. Additionally, it could influence competitors within the orthopedic, prosthetic, and surgical appliances industry as they adapt to technological advancements.
What's Next
CollPlant's extraordinary general meeting is scheduled for November 24, 2026, where shareholders will vote on the proposed name change to OptiPhi Computing Ltd. The filing does not specify any further actions beyond this meeting.
Read Next
Nuran Wireless outlines growth potential in tower portfolio
Amarc Resources provides operational update in 6-K filing
Genmab A/S Reports Executive Share Transactions Amid Activity
Skillful Craftsman Education Technology appoints new CFO
PolyPid reports Q3 2026 results, eyes FDA decision on D-PLEX20
Alpha Tau Medical to Host Investor Call on Glioblastoma Data










